19 June 2013
Keywords: ciba, expands, deal, isis, antisense, reinforced, its
Article | 26 February 1996
Ciba has reinforced its commitment to antisense research by
significantly expanding its five-year-old agreement with Isis
Pharmaceuticals to include a ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
26 February 1996
19 February 1996
© 2013 thepharmaletter.com